Analgesic infusion pumps are instruments used to carry analgesic drugs directly into patient’s body directly for pain management. Analgesic drugs provide relief from chronic disorders, including complex regional pain syndrome (CRPS), failed back syndrome pain, myocardial infarction, pneumonia, myocardial ischemia, post-operative pain, and hypertension. Lidocaine, phenol and morphine are some of the common medicines used in analgesic infusion pumps.
Explore Report At: https://www.psmarketresearch.com/market-analysis/analgesic-infusion-pumps-market/report-sample
On the basis of different product classes, analgesia infusion pumps market can be broadly categorized as ambulatory analgesia infusion pumps, syringe analgesia infusion pumps and volumetric analgesia infusion pumps. On the basis of end users, the global analgesia infusion pumps market can be categorized as hospitals and home care. And in terms of application, the analgesia infusion pumps market can be segmented as post-surgery application, labor pain, accident and trauma, and cancer patients.
Ageing population of the western countries, rising incidences of chronic diseases, technological advancements in the field of precision and accuracy, rising application of infusion pumps and growing home care market for infusion systems are the growth drivers for analgesia infusion pumps market.
Globally, North America is the largest market for analgesic infusion pumps, and followed by Europe. Presence of well-developed healthcare infrastructure, high acceptance of technologically superior products and increasing adoption rates are the major factor behind the dominance of North America in analgesia infusion pumps market.
Some of the key competitors of analgesic infusion pumps market are B. Braun Melsungen AG, KD Scientific Inc., Animas Corporation, Hospira Inc., Terumo Corporation, Codman & Shurtleff Inc., Stryker Corp., Medtronic Inc., and Smiths Medical.
No comments:
Post a Comment